In this study, we first found the positive therapeutic effect of ILG in vivo in a PD mouse model, and confirmed that ILG reduced neuroinflammation in a PD model and validated the effect of ILG on the Nrf2/NQO-1 signaling pathway in a PD model. The gene discussed is NQO1; the disease is Parkinson disease.